Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Nov;63(11):4358-67.
doi: 10.1128/iai.63.11.4358-4367.1995.

Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica

Affiliations

Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica

P Arhets et al. Infect Immun. 1995 Nov.

Abstract

The redistribution and capping of surface receptors on the human pathogen Entamoeba histolytica was observed in the presence of concanavalin A (ConA). Capping was correlated with plasma membrane folding towards the rear of the amoeba and with uroid formation. The uroid is thought to play a role in the escape of amoebae from the host immune response. To localize myosin II during capping, amoebae were incubated in the presence of ConA and then analyzed by microscopy. Myosin II was three times more concentrated within the uroid compared with the rest of the cell, suggesting that the release of caps may depend upon mechanical contraction driven by myosin II activity. The use of drugs that disrupt cytoskeletal structure or that inhibit myosin heavy chain phosphorylation demonstrated that inhibition of capping prevents uroid formation. Biochemical analysis allowed the identification of two ConA receptors which have been previously described as major pathogenic antigens of this parasite: the 96-kDa antigen, which carries alcohol dehydrogenase 2 activity and binds extracellular matrix proteins, and the Gal-GalNAc-inhibitable surface lectin, which is involved in amoeba-cell interactions and in the degradation of complement particles attached to the parasite.

PubMed Disclaimer

References

    1. J Cell Biol. 1991 Feb;112(4):677-88 - PubMed
    1. Mol Biochem Parasitol. 1993 May;59(1):123-31 - PubMed
    1. J Clin Invest. 1992 Sep;90(3):1131-7 - PubMed
    1. J Immunol. 1990 Mar 15;144(6):2242-52 - PubMed
    1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources